Hexaphyrin as a Potential Theranostic Dye for Photothermal Therapy and 19 F Magnetic Resonance Imaging.
Tomohiro HigashinoHirotaka NakatsujiRyosuke FukudaHaruki OkamotoHirohiko ImaiTetsuya MatsudaHidehito TochioMasahiro ShirakawaNikolai V TkachenkoMitsuru HashidaTatsuya MurakamiHiroshi ImahoriPublished in: Chembiochem : a European journal of chemical biology (2017)
Two features of meso-Aryl-substituted expanded porphyrins suggest suitability as theranostic agents. They have excellent absorption in near infrared (NIR) region, and they offer the possibility of introduction of multiple fluorine atoms at structurally equivalent positions. Here, hexaphyrin (hexa) was synthesized from 2,6-bis(trifluoromethyl)-4-formyl benzoate and pyrrole and evaluated as a novel expanded porphyrin with the above features. Under NIR illumination hexa showed intense photothermal and weak photodynamic effects, which were most likely due to its low excited states, close to singlet oxygen. The sustained photothermal effect caused ablation of cancer cells more effectively than the photodynamic effect of indocyanine green (a clinical dye). In addition, hexa showed potential for use in the visualization of tumors by 19 F magnetic resonance imaging (MRI), because of the multiple fluorine atoms. Our results strongly support the utility of expanded porphyrins as theranostic agents in both photothermal therapy and 19 F MRI.
Keyphrases
- photodynamic therapy
- magnetic resonance imaging
- contrast enhanced
- fluorescence imaging
- computed tomography
- cancer therapy
- positron emission tomography
- diffusion weighted imaging
- pet imaging
- highly efficient
- human health
- drug release
- molecular docking
- magnetic resonance
- drug delivery
- energy transfer
- climate change
- ionic liquid
- risk assessment